Skip to content

Effects of chicken essence supplementation on post-exercise hypotension in prehypertensive individuals

Effects of chicken essence supplementation on post-exercise hypotension in prehypertensive individuals

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240330003
Enrollment
10
Registered
2024-03-30
Start date
2023-05-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prehypertensive individuals Essence of chicken, blood pressure, prehypertension, heart rate variability

Interventions

There is no exercise and no intervention involved.,The CON group performed exercise without consuming the essence of chicken. ,The CES group performed exercise with consuming the essence of chicken.
No Intervention No treatment,Placebo Comparator No treatment,Experimental Dietary Supplement
REST,CON,CES

Sponsors

Faculty of Sports Science, Kasetsart University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 22 Years

Inclusion criteria

Inclusion criteria: 1. Prehypertensive males aged 18 to 22 years (SBP 120 to 139 mmHg or diastolic BP (DBP) 80 to 89 mmHg) 2. Sedentary lifestyle, defined as having less than 1 hr of regular exercise training per week 3. Parents' history of HT was defined as treatment for essential HT (stage 1 or 2) for at least 2 years

Exclusion criteria

Exclusion criteria: Participants were excluded if they were (1) current smokers; (2) taking any medication that might influence cardiometabolism; (3) had musculoskeletal limitations to physical exercise; (4) had any psychiatric problems; or (5) had been on a weight loss diet in the previous 6 months.

Design outcomes

Primary

MeasureTime frame
24-hr ambulatory BP prior to and 24 hr after the study protocol session an ABPM device (Walk200b, Cardioline) based on oscillometry with step deflation

Secondary

MeasureTime frame
HRV recordings and analysis prior to and 24 hr after the study protocol session an electrocardiogram (ECG) (eMotion Faros device, Mega Electronics, Kuopio, Finland),baPWV prior to and 24 hr after the study protocol session PWV analysis

Countries

Thailand

Contacts

Public ContactJatuporn Phoemsapthawee

Faculty of Sports Science, Kasetsart University

jatuporn.w@ku.th034355258

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026